Autoantibodies in the serum of patients with malignant melanoma
Młodkowska, A.; Danowska, A.
Polski Przeglad Chirurgiczny 50(10): 841-843
1978
ISSN/ISBN: 0032-373X PMID: 310545 Document Number: 131718
Document emailed within 1 workday
Related Documents
Agrup, P.; Carstam, R.; Wittbjer, A.; Rorsman, H.; Rosengren, E. 1989: Tyrosinase activity in serum from patients with malignant melanoma Acta Dermato-Venereologica 69(2): 120-124Popović, S.; Roguljić, A.; Nola, P.; Maricić, Z. 1975: Diagnostic significance of serum hemopexin in patients with malignant melanoma Lijecnicki Vjesnik 97(4): 241-244
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Bonfrer, J.M.; Korse, C.M.; Israels, S.P. 1997: Serum S-100 has prognostic significance in malignant melanoma Anticancer Research 17(4b): 2975-2977
Ikeda, S.; Ishihara, K.; Taguchi, G. 1985: Phase IIi study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 77-85
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Komov, O.P. 1970: Detection of serum autoantibodies in patients with psoriasis Vestnik Dermatologii i Venerologii 44(9): 24-27
Faiderbe, S.; Chagnaud, J.L.; Charrier, M.C.; Peyron, M.A.; Wafflart, J.; Geffard, M. 1991: Autoantibodies directed against lipid membrane components in sera of patients with malignant tumors Cancer Detection and Prevention 15(3): 199-203
Rahmati, K.; Åke Lernmark; Becker, C.; Foltyn, A.-Zadura; Larsson, K.; Sten-Ivarsson, A.; Carina Törn 2008: A Comparison of Serum and EDTA Plasma in the Measurement of Glutamic Acid Decarboxylase Autoantibodies (GADA) and Autoantibodies to Islet Antigen-2 (IA-2A) Using the RSR Radioimmunoassay (RIA) and Enzyme Linked Immunosorbent Assay (ELISA) Kits Clinical Laboratory 54(7-8): 227-235
Kamchatov, P.R.; Ruleva, N.I.; Dugin, S.F.; Buriachkovskaia, L.I.; Chugunov, A.V.; Mikhaĭlova, N.A.; Basse, D.A. 2009: Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(5 Suppl 2: 69-72
Stenger, D.; Delbrück, H.; Krumrey, K.; Zaun, H. 1983: Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans Zeitschrift für Hautkrankheiten 58(5): 293-304
Zielińska, E.; Michalak, T.; Dymowska, Z. 1979: Incidence of autoantibodies in the blood serum of patients with serologically confirmed Toxoplasma gondii infection Medycyna Doswiadczalna i Mikrobiologia 31(4): 271-276
Suchan, M. 1974: Formation of antierythrocytic autoantibodies in vitro in serum of patients with so-called autoimmune haemolytic anaemia Sbornik Lekarsky 76(7): 221-224
Mantzavinos, T.; Dalamanga, N.; Hassiakos, D.; Dimitriadou, F.; Konidaris, S.; Zourlas, P.A. 1993: Assessment of autoantibodies to the zona pellucida in serum and follicular fluid in in-vitro fertilization patients Clinical and Experimental Obstetrics and Gynecology 20(2): 111-115
Gusev, E.I.; Skvortsova, V.I.; Izykenova, G.A.; Alekseev, A.A.; Dambinova, S.A. 1996: The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 96(5): 68-72
Nairn, R.C.; Nind, A.P.; Guli, E.P.; Davies, D.J.; Little, J.H.; Davis, N.C.; Whitehead, R.H. 1972: Anti-tumor immunoreactivity in patients with malignant melanoma Medical Journal of Australia 1(9): 397-403
Kovarík, J.; Ninger, E.; Mechl, Z.; Zemanová, D.; Lauerová, L.; Sopková, B.; Svejda, J.; Bacovský, B.; Bártová, A.; Bártek, J. 1983: Immunotherapy and immune competence of patients with malignant melanoma Czechoslovak Medicine 6(3): 172-174
Masserini, C.; Villa, M.L.; Rovini, D.; Clerici, E. 1981: Natural killer activity in patients with malignant melanoma Bollettino dell'Istituto Sieroterapico Milanese 60(4): 307-315
Boland, S.L.; Shaw, H.M.; Milton, G.W. 1976: Multiple primary cancers in patients with malignant melanoma Medical Journal of Australia 1(15): 517-519
Arlen, M.; Hollinshead, A.; Scherrer, J. 1977: Tumor-specific immunity in patients with malignant melanoma Surgical Forum 28: 168-169